Generation of efficacy data on 60 years and older population using SARS-CoV-2 vaccines
As of March 31, 2021 nine vaccines against coronavirus-2019 disease (COVID-19 flu) were approved globally, which include ChAdOx1 (AZS1222) (AstraZeneca/Oxford, UK), COVAXIN (Bharat Biotech, India), BNT162b2 (Pfizer-BioNTech, USA), mRNA-1273 (Moderna, USA), ADENO 26 CoV2.S (Johnson &Johnson, USA)...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Series: | MGM Journal of Medical Sciences |
| Subjects: | |
| Online Access: | http://www.mgmjms.com/article.asp?issn=2347-7946;year=2021;volume=8;issue=3;spage=289;epage=296;aulast=Ghosh |